Across TCGA pan-cancer cohorts, C15orf32 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated C15orf32 data layer compared with 2 for mutation status.
The strongest signal is observed in uveal melanoma (UVM), where higher C15orf32 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated C15orf32 expression acts as an unfavorable survival marker, although some lineages such as UCS and SCLC show a favorable association.
UVM, COAD, and LUAD are the cancer types where C15orf32 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.